πŸ‡ΊπŸ‡Έ FDA
Patent

US 9750748

Pyridazinones as DAAO enzyme inhibitors

granted A61KA61K31/277A61K31/496

Quick answer

US patent 9750748 (Pyridazinones as DAAO enzyme inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/277, A61K31/496, A61K31/50, A61K31/501